Aeglea BioTherapeutics Inc. Common Stock. Replay the stock market charts of AGLE day by day back to 2003. Open long and short positions without spending any money. Aeglea BioTherapeutics Inc is a biopharmaceutical company committed to developing enzyme-based therapeutics in the field of amino acid metabolism, which will transform the lives of patients with inborn errors of metabolism and cancer.